Evome Medical Technologies Inc. (TSXV:EVMT)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
At close: May 6, 2025
Evome Medical Technologies Earnings Call Transcripts
Fiscal Year 2024
-
Q2 2024 saw strong revenue and profit growth in the core business, with positive adjusted EBITDA and significant debt reduction. Asset sales and a new white-labeling strategy are set to further improve financial health and drive growth in 2025.
-
Significant turnaround achieved with cost cuts, asset sales, and new product launches driving revenue growth. Plans include further debt reduction, expansion into private physical therapy, and continued innovation, with positive financial momentum expected.